Decreased PITX1 gene expression in human cutaneous malignant melanoma and its clinicopathological significance

European Journal of Dermatology

Volumn 23, Issue 3, 2013, Pages 344-349

  Osaki, Mitsuhiko ^a   Chinen, Hikari ^a   Yoshida, Yuichi ^a   Ohhira, Takahito ^a   Sunamura, Naohiro ^a   Yamamoto, Osamu ^a   Ito, Hisao ^a   Oshimura, Mitsuo ^a   Kugoh, Hiroyuki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Ki 67; Malignant melanoma; PITX1; Tumor progression

Indexed keywords

KI 67 ANTIGEN; HOMEOBOX PROTEIN PITX1; PAIRED BOX TRANSCRIPTION FACTOR;

AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS MELANOMA; FEMALE; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MELANOCYTE; METASTASIS; PITX1 GENE; SKIN CARCINOGENESIS; TUMOR VOLUME; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; MELANOMA; PROGNOSIS;

AGED; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; PAIRED BOX TRANSCRIPTION FACTORS; PROGNOSIS;

EID: 84880604654     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.2021     Document Type: Article

References (21)

1. Bleyer A, Viny A, Barr R. Cancer in 15-to 29-year-olds by primary site. Oncologist 2006; 11: 590-601.
2. Chen H, Takahara M, Oba J, et al. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci 2011; 64: 39-44.
3. Vahrmeijer AL, de Velde CJ, Hartgrink HH, Tollenaar RA. Treatment of melanoma metastases confined to the liver and future perspectives. Dig Surg 2008; 25: 467-72.
4. Karbowniczek M, Spittle CS, Morrison T, Wu H, Henske EP. mTOR is activated in the majority of malignant melanomas. J Invest Dermatol 2008; 128: 980-7.
5. Lasithiotakis KG, Sinnberg TW, Schittek B, et al. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells. J Invest Dermatol 2008; 128: 2013-23.
6. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
7. Qi DL, Ohhira T, Fujisaki C, et al. Identification of PITX1 as a TERT suppressor gene located on human chromosome 5. Mol Cell Biol 2011; 31: 1624-36.
8. Shang J, Li X, Ring HZ, Clayton DA, Francke U. Backfoot, a novel homeobox gene, maps to human chromosome 5 (BFT) and mouse chromosome 13 (Bft). Genomics 1997; 40: 108-13.
9. Lamonerie T, Tremblay JJ, Lanctot C, Therrien M, Gauthier Y, Drouin J. Ptx1, a bicoid-related homeobox transcription factor involved in transcription of the pro-opiomelanocortin gene. Gene Dev 1996; 10: 1284-95.
10. DeLaurier A, Schweitzer R, Logan M. Pitx1 determines the morphology of muscle, tendon, and bones of the hindlimb. Dev Biol 2006; 299: 22-34.
11. Logan M, Simon HG, Tabin C. Differential regulation of T-box and homeobox transcription factors suggests roles in controlling chick limb-type identity. Development 1998; 125: 2825-35.
12. Logan M, Tabin CJ. Role of Pitx1 upstream of Tbx4 in specification of hindlimb identity. Science 1999; 283: 1736-9.
13. Shang J, Luo Y, Clayton DA. Backfoot is a novel homeobox gene expressed in the mesenchyme of developing hindlimb. Dev Dynam 1997; 209: 242-53.
14. Imoto I, Pimkhaokham A, Watanabe T, Saito-Ohara F, Soeda E, Inazawa J. Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE superclass, in ovarian cancer cell lines. Biochem Biophys Res Commun 2000; 276: 264-70.
15. Lord RV, Brabender J, Wickramasinghe K, et al. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. Surgery 2005; 138: 924-31.
16. Kolfschoten IG, van Leeuwen B, Berns K, et al. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 2005; 121: 849-58.
17. Chen Y, Knösel T, Ye F, Pacyna-Gengelbach M, Deutschmann N, Petersen I. Decreased PITX1 homeobox gene expression in human lung cancer. Lung Cancer 2007; 55: 287-94.
18. Chen YN, Chen H, Xu Y, Zhang X, Luo Y. Expression of pituitary homeobox 1 gene in human gastric carcinogenesis and its clinicopathological significance. World J Gastroenterol 2008; 14: 292-7.
19. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 2001; 98: 15149-54.
20. Singh D, Febbo PG, Ross K, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002; 1: 203-9.
21. Ji Z, Flaherty KT, Tsao H. Targeting the RAS pathway in melanoma. Trends Mol Med 2012; 18: 27-35.